GB0103046D0 - Organic Compounds - Google Patents

Organic Compounds

Info

Publication number
GB0103046D0
GB0103046D0 GBGB0103046.9A GB0103046A GB0103046D0 GB 0103046 D0 GB0103046 D0 GB 0103046D0 GB 0103046 A GB0103046 A GB 0103046A GB 0103046 D0 GB0103046 D0 GB 0103046D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
antimycotics
compound
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0103046.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0103046.9A priority Critical patent/GB0103046D0/en
Publication of GB0103046D0 publication Critical patent/GB0103046D0/en
Priority to SK999-2003A priority patent/SK9992003A3/sk
Priority to SI200230146T priority patent/SI1370513T1/xx
Priority to CA002437592A priority patent/CA2437592A1/en
Priority to CN028046080A priority patent/CN1216034C/zh
Priority to IL15724102A priority patent/IL157241A0/xx
Priority to BR0207077-4A priority patent/BR0207077A/pt
Priority to RU2003126176/04A priority patent/RU2289570C2/ru
Priority to DE60203890T priority patent/DE60203890T2/de
Priority to AT02704689T priority patent/ATE294154T1/de
Priority to US10/470,885 priority patent/US20040147603A1/en
Priority to AU2002238534A priority patent/AU2002238534C1/en
Priority to KR1020037010291A priority patent/KR100859609B1/ko
Priority to DK02704689T priority patent/DK1370513T3/da
Priority to MXPA03007072A priority patent/MXPA03007072A/es
Priority to KR1020087010521A priority patent/KR20080041756A/ko
Priority to EP02704689A priority patent/EP1370513B1/en
Priority to HU0303174A priority patent/HUP0303174A3/hu
Priority to JP2002569776A priority patent/JP4078206B2/ja
Priority to PT02704689T priority patent/PT1370513E/pt
Priority to CZ20032132A priority patent/CZ20032132A3/cs
Priority to PCT/EP2002/001249 priority patent/WO2002070455A1/en
Priority to PL362554A priority patent/PL204812B1/pl
Priority to ES02704689T priority patent/ES2240698T3/es
Priority to NZ527300A priority patent/NZ527300A/en
Priority to HK04103924.1A priority patent/HK1060876B/en
Priority to IL157241A priority patent/IL157241A/en
Priority to NO20033473A priority patent/NO20033473L/no
Priority to ZA200306029A priority patent/ZA200306029B/en
Priority to EC2003004713A priority patent/ECSP034713A/es
Priority to US11/606,268 priority patent/US7488759B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
GBGB0103046.9A 2001-02-07 2001-02-07 Organic Compounds Ceased GB0103046D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds
HK04103924.1A HK1060876B (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
MXPA03007072A MXPA03007072A (es) 2001-02-07 2002-02-06 Sales de adicion de acido malico de terbinafina.
KR1020087010521A KR20080041756A (ko) 2001-02-07 2002-02-06 테르비나핀의 말산 부가염을 포함하는 제약 조성물
CA002437592A CA2437592A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
CN028046080A CN1216034C (zh) 2001-02-07 2002-02-06 特比萘芬的苹果酸加成盐
IL15724102A IL157241A0 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
BR0207077-4A BR0207077A (pt) 2001-02-07 2002-02-06 Sais de adição do ácido málico da terbinafina
RU2003126176/04A RU2289570C2 (ru) 2001-02-07 2002-02-06 Кислотно-аддитивные соли тербинафина и яблочной кислоты, способ их получения и фармацевтическая композиция для лечения грибковой инфекции
DE60203890T DE60203890T2 (de) 2001-02-07 2002-02-06 Apfelsäureadditionssalze von terbinafin
AT02704689T ATE294154T1 (de) 2001-02-07 2002-02-06 Apfelsäureadditionssalze von terbinafin
US10/470,885 US20040147603A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
AU2002238534A AU2002238534C1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
KR1020037010291A KR100859609B1 (ko) 2001-02-07 2002-02-06 테르비나핀의 말산 부가염
DK02704689T DK1370513T3 (da) 2001-02-07 2002-02-06 Æblesyreadditionssalte af terbinafin
SK999-2003A SK9992003A3 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine, method for the preparation thereof and pharmaceutical compositions comprising same
EP02704689A EP1370513B1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
PT02704689T PT1370513E (pt) 2001-02-07 2002-02-06 Sais de adicao do acido malico de terbinafina
SI200230146T SI1370513T1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
JP2002569776A JP4078206B2 (ja) 2001-02-07 2002-02-06 テルビナフィンのリンゴ酸付加塩
HU0303174A HUP0303174A3 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them
CZ20032132A CZ20032132A3 (cs) 2001-02-07 2002-02-06 Adiční soli terbinafinu s kyselinou jablečnou, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
PCT/EP2002/001249 WO2002070455A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
PL362554A PL204812B1 (pl) 2001-02-07 2002-02-06 Sole terbinafiny z kwasem jabłkowym, sposób wytwarzania tych soli, ich zastosowanie, kompozycja farmaceutyczna zawierająca wspomniane sole oraz sposób wytwarzania tej kompozycji
ES02704689T ES2240698T3 (es) 2001-02-07 2002-02-06 Sales malicas de adicion acida de terbinafina.
NZ527300A NZ527300A (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine
IL157241A IL157241A (en) 2001-02-07 2003-08-04 Turbine finic acid adsorbent salts, processes for their manufacture and medicinal preparations containing them
NO20033473A NO20033473L (no) 2001-02-07 2003-08-05 Eplesyreaddisjonssalter av terbinafin
ZA200306029A ZA200306029B (en) 2001-02-07 2003-08-05 Malic acid addition salts of terbinafine.
EC2003004713A ECSP034713A (es) 2001-02-07 2003-08-06 Sales de adicion de acido malico de terbinafina
US11/606,268 US7488759B2 (en) 2001-02-07 2006-11-29 Malic acid addition salts of terbinafine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds

Publications (1)

Publication Number Publication Date
GB0103046D0 true GB0103046D0 (en) 2001-03-21

Family

ID=9908301

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0103046.9A Ceased GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds

Country Status (27)

Country Link
US (2) US20040147603A1 (enExample)
EP (1) EP1370513B1 (enExample)
JP (1) JP4078206B2 (enExample)
KR (2) KR20080041756A (enExample)
CN (1) CN1216034C (enExample)
AT (1) ATE294154T1 (enExample)
AU (1) AU2002238534C1 (enExample)
BR (1) BR0207077A (enExample)
CA (1) CA2437592A1 (enExample)
CZ (1) CZ20032132A3 (enExample)
DE (1) DE60203890T2 (enExample)
DK (1) DK1370513T3 (enExample)
EC (1) ECSP034713A (enExample)
ES (1) ES2240698T3 (enExample)
GB (1) GB0103046D0 (enExample)
HU (1) HUP0303174A3 (enExample)
IL (2) IL157241A0 (enExample)
MX (1) MXPA03007072A (enExample)
NO (1) NO20033473L (enExample)
NZ (1) NZ527300A (enExample)
PL (1) PL204812B1 (enExample)
PT (1) PT1370513E (enExample)
RU (1) RU2289570C2 (enExample)
SI (1) SI1370513T1 (enExample)
SK (1) SK9992003A3 (enExample)
WO (1) WO2002070455A1 (enExample)
ZA (1) ZA200306029B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209339A1 (en) * 2002-07-02 2005-09-22 Ercem Atillasoy Methods for the treatment of sinusitis
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
RU2286144C2 (ru) * 2004-12-02 2006-10-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВСиДВ СО РАСХН) Способ лечения микроспории кошек
WO2007104474A1 (en) * 2006-03-10 2007-09-20 Novartis Ag Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid
EP2043604A2 (en) 2006-06-14 2009-04-08 Dr. Reddy's Laboratories Ltd. Topical compositions
RU2350343C1 (ru) * 2007-08-13 2009-03-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВС и ДВ СО Россельхозакадемии) Способ лечения микроспории кошек
KR101733773B1 (ko) 2009-01-16 2017-05-10 엑셀리시스, 인코포레이티드 Ｎ-（４-｛〔６，７-비스（메틸옥시）퀴놀린-4-일〕옥시｝페닐）-ｎ＇-（４-플루오로페닐）사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
CN106106449A (zh) * 2016-06-21 2016-11-16 广西中烟工业有限责任公司 特比萘芬制剂及其在提高烟叶角鲨烯含量中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507755A (en) * 1967-10-17 1970-04-21 Bayer Ag Process for the purification of acrylonitrile by distillation with side stream withdrawal and decantation
US4276125A (en) 1979-02-02 1981-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of crude olefinically unsaturated nitrile and condenser useful for same process
US4269667A (en) 1979-08-02 1981-05-26 Standard Oil Company Acrylonitrile purification by extractive distillation
ATE10272T1 (de) * 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
KR850001603B1 (ko) 1980-12-03 1985-10-24 아사히 가세이 고오교오 가부시기가이샤 불포화 니트릴의 제조법
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
NZ227042A (en) * 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
CA2285368A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies Inc. Solvent system for enhanced penetration of pharmaceutical compounds
WO1999049895A2 (en) 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU758679B2 (en) * 1998-07-24 2003-03-27 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
JP2000053681A (ja) 1998-08-10 2000-02-22 Sankyo Co Ltd 三環性複素環化合物を含有する抗菌剤
ATE245624T1 (de) 1999-10-22 2003-08-15 Richter Gedeon Vegyeszet Verfahren zur herstellung substituierter allylamin derivative und deren salze
GB0014448D0 (en) 2000-06-13 2000-08-09 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物

Also Published As

Publication number Publication date
NZ527300A (en) 2005-02-25
HK1060876A1 (en) 2004-08-27
ECSP034713A (es) 2003-09-24
IL157241A (en) 2009-06-15
DE60203890T2 (de) 2006-01-19
HUP0303174A3 (en) 2008-03-28
ES2240698T3 (es) 2005-10-16
US7488759B2 (en) 2009-02-10
PL362554A1 (en) 2004-11-02
JP2004523567A (ja) 2004-08-05
CN1491206A (zh) 2004-04-21
PT1370513E (pt) 2005-08-31
NO20033473L (no) 2003-09-17
AU2002238534B2 (en) 2005-09-29
DE60203890D1 (de) 2005-06-02
ZA200306029B (en) 2004-06-28
JP4078206B2 (ja) 2008-04-23
EP1370513A1 (en) 2003-12-17
PL204812B1 (pl) 2010-02-26
BR0207077A (pt) 2004-01-20
US20040147603A1 (en) 2004-07-29
KR100859609B1 (ko) 2008-09-23
CZ20032132A3 (cs) 2003-10-15
HUP0303174A2 (hu) 2003-12-29
KR20030077606A (ko) 2003-10-01
EP1370513B1 (en) 2005-04-27
CA2437592A1 (en) 2002-09-12
RU2289570C2 (ru) 2006-12-20
DK1370513T3 (da) 2005-08-01
SK9992003A3 (en) 2004-01-08
ATE294154T1 (de) 2005-05-15
US20070088084A1 (en) 2007-04-19
MXPA03007072A (es) 2003-11-18
NO20033473D0 (no) 2003-08-05
SI1370513T1 (en) 2005-10-31
KR20080041756A (ko) 2008-05-13
RU2003126176A (ru) 2005-03-10
IL157241A0 (en) 2004-02-19
AU2002238534C1 (en) 2006-04-13
CN1216034C (zh) 2005-08-24
WO2002070455A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
PL369530A1 (en) Chemical compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
AU2003228770A8 (en) Substituted pyrazolopyrimidines
AU2002239344A1 (en) Pyrazolopyridines
UA94833C2 (en) Substituted bicyclolactams
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
IL176062A0 (en) Dpp-iv inhibitors
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
DE60112330D1 (en) Pyrazolopyridinderivate
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
GB0103046D0 (en) Organic Compounds
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
GB0212410D0 (en) Organic compounds
IL171992A0 (en) Storage-stable fluorescent whitener formulations
DE60201074D1 (en) Pyrazolopyridinderivate
PL1970372T3 (pl) Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami
WO2006023586A3 (en) Guanylhydrazone compounds, compositions, methods of making and using
GB0309440D0 (en) Quinolone derivatives
GEP20084394B (en) Novel intermediate for the preparation of therapeutically active imidazopyridines
WO2007079173A3 (en) Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)